Microbial Theranostics: A Resistance Combating Strategy – Mayo Clinic’s Robin Patel, MD
The Levy CIMAR proudly welcomes the Mayo Clinic’s Robin Patel, MD, to present for our March ’22 monthly Science Lunch. Among her many titles at Mayo, Dr. Patel is an Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of Microbiology, and the Director of the Infectious Diseases Research Laboratory. In the research laboratory, she and her colleagues focus on biofilms, which cause a large number of infections in modern clinical practice, such as prosthetic joint infection and endocarditis.
Dr. Patel and her team are unraveling the process of biofilm formation and resistance of biofilms to antibiotics. They are developing new and improved diagnostic tools and treatment strategies for biofilm-associated infections. Her group uses in vitro studies as well as animal models of infection for their studies.
Dr. Patel is also co-Director of the Bacteriology Laboratory. There, she and her colleagues aim to offer state-of-the-art assays for clinical detection of bacteria, identification of bacteria, and characterization of antimicrobial resistance and susceptibility. In the laboratory itself, they develop many of the bacteriology assays offered for patient care at the Mayo Clinic, providing the most technologically and clinically relevant diagnostics possible.